ALLO insider trading
Open-market stock trades by Allogene Therapeutics (ALLO) executives and directors: who bought or sold, how many shares, at what price and when.
ALLO insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell | 36,342 | $1.34 | $48.70K |
| Aug 21, 2026 | Douglas Earl Martin | SVP, General Counsel | Sell | 29,697 | $2.12 | $62.96K |
| Apr 21, 2026 | Yoshiyama Annie | SVP, Finance | Sell | 9,586 | $2.31 | $22.14K |
| Mar 31, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 2,867 | $2.50 | $7.17K |
| Mar 16, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 4,835 | $2.47 | $11.94K |
| Mar 16, 2026 | Chang David D | President and CEO | Sell | 47,763 | $2.47 | $117.97K |
| Mar 2, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 7,132 | $2.60 | $18.54K |
| Feb 2, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 7,549 | $1.73 | $13.06K |
| Feb 2, 2026 | Chang David D | President and CEO | Sell | 95,269 | $1.80 | $171.48K |
| Feb 2, 2026 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell | 24,001 | $1.76 | $42.24K |
| Feb 2, 2026 | Douglas Earl Martin | SVP, General Counsel | Sell | 22,900 | $1.76 | $40.30K |
| Feb 2, 2026 | Yoshiyama Annie | SVP, Finance | Sell | 4,167 | $1.72 | $7.17K |
| Feb 2, 2026 | Roberts Zachary | EVP of R&D | Sell | 35,700 | $1.77 | $63.19K |
| Jan 21, 2026 | Roberts Zachary | EVP of R&D | Sell | 26,269 | $1.56 | $40.98K |
| Nov 17, 2025 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 786 | $1.22 | $958.92 |
| Oct 21, 2025 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell | 36,744 | $1.26 | $46.17K |
| Jun 10, 2025 | MESSEMER DEBORAH M. | director | Sell | 36,885 | $1.42 | $52.38K |
| Apr 21, 2025 | Yoshiyama Annie | SVP, Finance | Sell | 9,601 | $1.41 | $13.54K |
| Mar 14, 2025 | Chang David D | President and CEO | Sell | 46,668 | $1.96 | $91.47K |
| Mar 14, 2025 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell | 5,488 | $1.98 | $10.84K |
| Feb 18, 2025 | MESSEMER DEBORAH M. | director | Sell | 13,313 | $2.43 | $32.35K |
| Feb 3, 2025 | Douglas Earl Martin | SVP, General Counsel | Sell | 6,404 | $1.71 | $10.95K |
| Feb 3, 2025 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell | 4,361 | $1.73 | $7.54K |
| Feb 3, 2025 | MOORE TIMOTHY L. | Chief Technical Officer | Sell | 14,746 | $1.71 | $25.22K |
| Feb 3, 2025 | Chang David D | President and CEO | Sell | 46,003 | $1.68 | $77.29K |
| Feb 3, 2025 | Roberts Zachary | EVP of R&D | Sell | 18,832 | $1.70 | $32.01K |
| Jan 21, 2025 | Roberts Zachary | EVP of R&D | Sell | 27,199 | $1.78 | $48.41K |
| Dec 9, 2024 | MESSEMER DEBORAH M. | director | Sell | 9,136 | $2.18 | $19.92K |
| Dec 5, 2024 | Humer Franz B | director | Sell | 9,221 | $2.16 | $19.92K |
| Jun 18, 2024 | MESSEMER DEBORAH M. | director | Sell | 18,641 | $2.28 | $42.49K |
| May 30, 2024 | Humer Franz B | director | Sell | 11,200 | $2.34 | $26.18K |
| May 16, 2024 | Belldegrun Arie | director | Buy | 1,724,137 | $2.90 | $5.00M |
- ALLO insiders bought $5.00M and sold $1.23M in open-market trades over their last 32 filings.
Updated 2026-11-02 17:54 UTC